Bob Kramer, Emergent BioSolutions CEO

Emer­gent award­ed $379M+ to sup­ply the DOD with a skin de­con­t­a­m­i­na­tion lo­tion

Mary­land-based man­u­fac­tur­er Emer­gent BioSo­lu­tions is kick­ing off the new year with a mul­ti­mil­lion-dol­lar con­tract to sup­ply a lo­tion used in case of chem­i­cal at­tacks.

Emer­gent said on Thurs­day that it has inked an “in­def­i­nite-de­liv­ery” and “in­def­i­nite-quan­ti­ty” pro­cure­ment con­tract to sup­ply RS­DL kits, or re­ac­tive skin de­con­t­a­m­i­na­tion lo­tion, for use by all branch­es of the US mil­i­tary. The con­tract’s val­ue is worth up to $379.6 mil­lion, and Emer­gent’s Cana­di­an sub­sidiary will serve as the sub­con­trac­tor to sup­ply the lo­tion kits to the DOD. Emer­gent’s stock $EBS was up around 9% on Fri­day af­ter­noon.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.